Overview
Claude Denham is an Oncologist and an Internal Medicine provider in Dallas, Texas. Dr. Denham has been practicing medicine for over 43 years and is rated as an Experienced provider by MediFind in the treatment of Virilizing Ovarian Tumor. His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Bone Tumor, Mesothelioma, and Thymectomy.
His clinical research consists of co-authoring 4 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
Accepted plan types not found. Please verify directly with the provider.
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- PPO
- HMO
- POS
- MANAGED MEDICAID PLAN
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
3410 Worth Street, Suite 400, Dallas, TX 75246
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Claude Stringer is a Gynecologic Oncologist and an Oncologist in Dallas, Texas. Dr. Stringer is rated as a Distinguished provider by MediFind in the treatment of Virilizing Ovarian Tumor. His top areas of expertise are Ovarian Carcinosarcoma, Virilizing Ovarian Tumor, Testicular Yolk Sac Tumor, Malignant Mixed Mullerian Tumor, and Oophorectomy. Dr. Stringer is currently accepting new patients.
Texas Oncology, P.A.
Laura Divine is an Oncologist and an Obstetrics and Gynecologist in Dallas, Texas. Dr. Divine has been practicing medicine for over 15 years and is rated as a Distinguished provider by MediFind in the treatment of Virilizing Ovarian Tumor. Her top areas of expertise are Ovarian Carcinosarcoma, Virilizing Ovarian Tumor, Testicular Yolk Sac Tumor, Hysterectomy, and Oophorectomy.
Oncology-Hematology Consultants PA
Alan Munoz is a Gynecologic Oncologist and an Oncologist in Dallas, Texas. Dr. Munoz is rated as a Distinguished provider by MediFind in the treatment of Virilizing Ovarian Tumor. His top areas of expertise are Virilizing Ovarian Tumor, Ovarian Carcinosarcoma, Testicular Yolk Sac Tumor, Oophorectomy, and Bladder Reconstruction. Dr. Munoz is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Lung CancerDr. Denham isAdvanced. Learn about Lung Cancer.
- Pleuropulmonary BlastomaDr. Denham isAdvanced. Learn about Pleuropulmonary Blastoma.
- Experienced
- Adult Soft Tissue SarcomaDr. Denham isExperienced. Learn about Adult Soft Tissue Sarcoma.
- ALK-Positive Non-Small Cell Lung CancerDr. Denham isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Alveolar Soft Part SarcomaDr. Denham isExperienced. Learn about Alveolar Soft Part Sarcoma.
- Anal CancerDr. Denham isExperienced. Learn about Anal Cancer.
- Anaplastic Thyroid CancerDr. Denham isExperienced. Learn about Anaplastic Thyroid Cancer.
- AngiosarcomaDr. Denham isExperienced. Learn about Angiosarcoma.